Showing results (91-100 of 164) with videos related to

Sort By:
Pageof 17
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2015
3'-Deoxy-3'-¹⁸F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancerAmarnath Challapalli, Tara Barwick, Rachel A Pearson, et al.
Infection Control and Hospital Epidemiology|February 10, 2009
Epidemiology of healthcare-associated bloodstream infection caused by USA300 strains of methicillin-resistant Staphylococcus aureus in 3 affiliated hospitalsTimothy C Jenkins, Bruce D McCollister, Rohini Sharma, et al.
Future Oncology (London, England)|April 25, 2023
PETAL protocol: a phase Ib study of pembrolizumab after transarterial chemoembolization in hepatocellular carcinomaPetros Fessas, Bernhard Scheiner, Antonio D'Alessio, et al.
Future Oncology (London, England)|July 27, 2021
Patient preferences for advanced hepatocellular carcinoma treatment: a multicountry stated preference studySiu Hing Lo, Rohini Sharma, Charlotte E Costentin, et al.
Medical Oncology (Northwood, London, England)|September 8, 2016
Prognostic sub-classification of intermediate-stage hepatocellular carcinoma: a multicenter cohort study with propensity score analysisRamya Ramaswami, David J Pinato, Keiichi Kubota, et al.
NPJ Precision Oncology|February 11, 2026
Itacitinib in advanced hepatocellular cancer following first line therapyAlessandro Troiani, Lingshan Hung, David J Pinato, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 23, 2019
68Ga-DOTATATE PET/CT parameters predict response to peptide receptor radionuclide therapy in neuroendocrine tumoursRohini Sharma, Wai Meng Wang, Siraj Yusuf, et al.
Oncogene|March 12, 2020
Immune-based therapies for hepatocellular carcinomaDavid J Pinato, Nadia Guerra, Petros Fessas, et al.
Pageof 17